Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Nowal J. Jamhour, MA
JCP
Original Research
A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression
February 22, 2011
James G. Barbee
,
Thomas R. Thompson
,
Nowal J. Jamhour
, et al
JCP
Original Research
The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder
July 1, 2004
James G. Barbee
,
Erich J. Conrad
,
Nowal J. Jamhour
JCP
Original Research
Lamotrigine as an Augmentation Agent in Treatment-Resistant Depression
August 15, 2002
James G. Barbee
,
Nowal J. Jamhour
